Vascular-homing peptides for cancer therapy

Area of Science:

• Biotechnology and Biomedical Engineering
• Oncology
• Molecular Biology

Background:

• Phage libraries have been instrumental in identifying tumor homing peptides (THPs) over the past 30 years.
• THPs selectively bind to tumor cells or their microenvironment, sparing normal cells.
• Targeting tumor vasculature with vascular-homing peptides enhances therapeutic agent efficacy in cancer therapy.

Purpose of the Study:

• To review recent advancements in the identification of vascular-homing peptides.
• To explore the therapeutic applications of these peptides in various cancer types.
• To highlight novel strategies for cancer treatment using vascular-homing peptides.

Main Methods:

• Extensive utilization of phage libraries for peptide identification.
• Characterization of peptide binding affinity to tumor cells and vasculature.
• Review of studies on therapeutic applications of identified peptides.

Main Results:

• Identification of numerous vascular-homing peptides targeting tumor vasculature.
• These peptides bind to receptors like pro-angiogenic factors, metalloproteinases, and integrins.
• Demonstrated potential for enhancing cancer therapy efficacy.

Conclusions:

• Vascular-homing peptides are promising candidates for novel cancer therapeutic strategies.
• Targeting tumor vasculature offers a viable approach to improve treatment outcomes.
• Continued research in this area could lead to significant advancements in oncology.